On December 26, 2023, Saba Capital Master Fund, Ltd., announced that on December 22, 2023 it has sent a letter to BlackRock Health Sciences Term Trust containing a shareholder proposal under Rule 14a-8, for presentation to the Company's shareholders at the Company's 2024 annual meeting of shareholders, to terminate the management agreement between BlackRock Health Sciences Term Trust and BlackRock Advisors, LLC, the form of which is attached to the Trust's Form N-2, filed with the Securities and Exchange Commission on December 9, 2019, as since amended or novated, shall be terminated by the Trust, pursuant to the right of stockholders as embodied in Section 12 of the Management Agreement and Section 15(a)(3) of the Investment Company Act of 1940, such termination to be effective no more than sixty days following the date hereof.